GlobeNewswire

Advantest Introduces New V93000 Wave Scale Millimeter Solution to Cost-Effectively Test 5G-NR mmWave Devices up to 70 GHz

Del

Platform Architecture Delivers High Parallelism and Multi-Site Testing Capability for Multi-Band Frequencies

TOKYO, May 07, 2019 (GLOBE NEWSWIRE) -- Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) has extended its V93000 system to cost-efficiently test the next generation of 5G-NR radio frequency devices and modules on a single scalable platform.  The new V93000 Wave Scale Millimeter solution has the high multi-site parallelism and versatility needed for multi-band millimeter-wave (mmWave) frequencies.  The operational range from 24 GHz to 44 GHz and 57 GHz to 70 GHz enables customers to reduce their time to market for new designs running at mmWave frequencies.

The highly integrated system is architecturally distinctive from other solutions by providing as many as 64 bi-directional mmWave ports based on a modular implementation.  This allows not only the use of different 5G and WiGig frequency modules, but also the addition of new modules as new frequency bands are rolled out worldwide.  Based on an innovative mmWave card cage with up to eight mmWave instruments, this highly versatile and cost-effective ATE solution performs on the level of high-end bench instruments.  The scalable system’s wideband testing functionality gives it the capability to handle full-rate modulation and de-modulation for ultra-wideband (UWB), 5G-NR mmWave up to 1 GHz, WiGig (802.11ad/ay) up to 2 GHz and antenna-in-package (AiP) devices in addition to beamforming and over-the-air testing.

“By delivering the industry’s first integrated, multi-site mmWave ATE test solution, we are providing a pathway for customers to lower the cost of test for their current and upcoming 5G-NR devices while leveraging their existing investments in our well-established Wave Scale RF testers,” said Juergen Serrer, executive vice president of the V93000 Business Unit within Advantest Corporation’s ATE Business Group.  “In particular, OSAT companies can benefit greatly from this flexible, scalable mmWave ATE solution.”

Early installations at customers testing both 5G and WiGig multi-band devices have been completed.  Advantest is now accepting orders for the new mmWave solution.

About Advantest Corporation

A world-class technology company, Advantest is the leading producer of automatic test equipment (ATE) for the semiconductor industry and a premier manufacturer of measuring instruments used in the design and production of electronic instruments and systems.  Its leading-edge systems and products are integrated into the most advanced semiconductor production lines in the world.  The company also focuses on R&D for emerging markets that benefit from advancements in nanotech and terahertz technologies, and has introduced multi-vision metrology scanning electron microscopes essential to photomask manufacturing, as well as groundbreaking 3D imaging and analysis tools.  Founded in Tokyo in 1954, Advantest established its first subsidiary in 1982, in the USA, and now has subsidiaries worldwide.  More information is available at www.advantest.com.

ADVANTEST CORPORATION
3061 Zanker Road
San Jose, CA 95134, USA
Judy Davies
Judy.davies@advantest.com

A video accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/e3f91f39-4d40-4011-92c7-212193262007

Om GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg saker fra GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra GlobeNewswire

Governance reform could see African economies benefit to tune of £23bn - PwC Global Economy Watch20.5.2019 12:00:00 CESTPressemelding

Continent-wide analysis of African economies demonstrates positive correlation between economic growth and rising governance indicators Ethiopia and Cote d’Ivoire demonstrate consistent annual average real per-capita growth of >5% since 2013 Particularly strong growth among East African economies (average 3% per capita), while Central Africa has struggled (fall by average 1.3%) Global analysis highlights slowdown in manufacturing sector linked to US-China trade war LONDON, May 20, 2019 (GLOBE NEWSWIRE) -- The latest edition of PwC’s bimonthly Global Economy Watch has found that African economies could receive a windfall of £23bn if each economy applied similar governance reforms equivalent to those made by Cote d’Ivoire since 2013. The continent-wide economic analysis modelled the performance of each country across six of the World Bank’s Worldwide Governance Indicators (2013-17), which covers aspects such as regulatory quality, rule of law and government effectiveness. The analysis ha

Levine Leichtman Capital Partners Promotes Monty Ismail to Senior Associate20.5.2019 11:00:00 CESTPressemelding

LOS ANGELES, May 20, 2019 (GLOBE NEWSWIRE) -- Levine Leichtman Capital Partners (“LLCP”), a Los Angeles-based private equity firm, is pleased to announce the promotion of Monty Ismail to Senior Associate. Mr. Ismail joined the London office of Levine Leichtman Capital Partners in 2018. Since that time, he has participated in several successful transactions, including the add-on acquisition of Globe Business Media Group for Law Business Research Ltd. and the recent acquisition of SK AeroSafety. As a dedicated member of the firm’s Structured Equity investment team, he will continue to monitor LLCP portfolio companies as well as be responsible for investment due diligence and analysis of new investment opportunities. “Monty has been an important member of the Levine Leichtman Capital Partners team. He has contributed significantly to the success of our London office and we are excited for his continued growth within the firm,” said Lauren Leichtman, LLCP’s co-founder. For more information

WindSim Names Donna Rennemo Chief Executive Officer20.5.2019 11:00:00 CESTPressemelding

TONSBERG, Norway and WESTLAKE VILLAGE, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- WindSim AS, the leading provider and pioneer of CFD (Computational Fluid Dynamics) based Wind Farm Design Tools (WFDT) utilized for the design of wind farms both onshore and offshore, has today announced that its board of directors has appointed Donna Rennemo as president and chief executive officer. This leadership appointment is effective immediately and follow the Board of Directors in WindSim and John Olaf Rømma agreement to step down as the company’s CEO. “We are fortunate to have someone of Donna Rennemo’s caliber and experience to step up to lead WindSim,” said Dag Honningsvåg, WindSim Chairman of the Board. “We are at a critical moment and we need renewed leadership to successfully implement our strategy and take advantage of the market opportunities ahead. Rennemo is a technology visionary with a proven track record of execution. She is a strong communicator who is customer focused with deep leader

TransCanna Executes LOI To Acquire The Business and Assets of Premier Indoor Cultivator Lyfted Farms20.5.2019 09:05:00 CESTPressemelding

VANCOUVER, British Columbia, May 20, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – TransCanna Holdings Inc. (CSE:TCAN: XETR: TH8) (“TransCanna” or the “Company”) is pleased to announce the execution of a non-binding Letter Of Intent dated May 17, 2019 (the “LOI”) with Lyfted Farms, Inc. (“Lyfted”), of Modesto, California, to acquire the business and assets of Lyfted (the “Proposed Acquisition”). Lyfted Farms is a state licensed producer of high quality indoor grown cannabis. The three permanent state licenses that Lyfted owns are for cultivation (nursery), cultivation (grow), and distribution. “The Proposed Acquisition includes an exceptional brand, with a range of high-end flower, growing revenues, fifty exotic and unique genetic strains and a team that’s been a staple in the Modesto valley with over two decades of cultivating experience. In short, this is another example of an ideal acquisition candidate for TransCanna that offers SKU velocity, growing revenues and branded products that

Fortuna CEO purchases company shares17.5.2019 21:00:00 CESTPressemelding

VANCOUVER, British Columbia, May 17, 2019 (GLOBE NEWSWIRE) -- Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) reports that Jorge A. Ganoza, Chief Executive Officer of the Company, has increased his equity position in the Company by acquiring 170,000 common shares on the open market at an average price of US$2.59 per share. An insider report filing reflecting the share acquisition has been made on the SEDI website at www.sedi.ca. About Fortuna Silver Mines Inc. Fortuna is a growth oriented, precious metal producer with its primary assets being the Caylloma silver mine in southern Peru, the San Jose silver-gold mine in Mexico and the Lindero gold Project, currently under construction, in Argentina. The Company is selectively pursuing acquisition opportunities throughout the Americas and in select other areas. For more information, please visit its website at www.fortunasilver.com. ON BEHALF OF THE COMPANY Carlos Baca Investor Relations Manager Trading symbols: NYSE: FSM | TSX: FVI Inves

Oxford Immunotec Welcomes Updated CDC Recommendations for Tuberculosis Screening and Testing of Healthcare Personnel17.5.2019 15:25:00 CESTPressemelding

OXFORD, United Kingdom and MARLBOROUGH, Mass., May 17, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced that it welcomes the updated Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel: Recommendations from the National Tuberculosis Controllers Association and CDC, 2019, published by the U.S. Centers for Disease Control and Prevention (CDC)1. These guidelines increase the focus on eradicating tuberculosis (TB) disease in the United States through an individual risk-based approach to screening and treatment for Healthcare Personnel (HCP). Key highlights from the updated guidelines include: Recommendation for TB Screening and Individual Based TB Risk Assessment on Hire : continue baseline screening of all HCPs upon hire with the addition of an individual risk assessment Recommendation to Focus Serial Testing on Higher Risk Individuals: decision to perform TB testing afte